Abbott Laboratories (ABT):企業の財務・戦略的SWOT分析

◆英語タイトル:Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1585
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Abbott Laboratories (ABT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Abbott Laboratories (Abbott) discovers, develops, manufactures and sells a diversified range of healthcare products including branded generic pharmaceuticals, diagnostic systems and tests, and pediatric and adult nutritional products. The company also offers various medical devices, including electrophysiology, heart failure, rhythm management, vascular and structural heart devices, and neuromodulation devices. It has research and development facilities in the US, China, Colombia, India, Singapore, Spain, and the UK; and operates manufacturing facilities across the world. The company markets products in North America, Latin America, the Middle East, Europe, Asia-Pacific and Africa. Abbott is headquartered in Abbott Park, Illinois, the US.

Abbott Laboratories Key Recent Developments

Apr 21,2020 Quest Diagnostics begins to perform COVID-19 Antibody Testing
Apr 16,2020 C-Hear Executive Dylan Rafaty reappointed as Vice-Chair to Committee On People with Disabilities by Texas Governor Greg Abbott
Apr 16,2020 Abbott reports first-quarter 2020 results
Feb 11,2020 Abbott Laboratories: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Abbott Laboratories – Key Facts
Abbott Laboratories – Key Employees
Abbott Laboratories – Key Employee Biographies
Abbott Laboratories – Major Products and Services
Abbott Laboratories – History
Abbott Laboratories – Company Statement
Abbott Laboratories – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Business Unit
Section 2 – Company Analysis
Company Overview
Abbott Laboratories – Business Description
Business Segment: Diagnostic Products
Overview
Performance
Key Stats
Business Segment: Established Pharmaceutical Products
Overview
Performance
Business Segment: Medical Devices
Overview
Performance
Key Stats
Business Segment: Nutritional Products
Overview
Performance
Key Stats
Business Segment: Others
Performance
Geographical Segment: All Other Countries
Performance
Geographical Segment: China
Performance
Geographical Segment: Germany
Performance
Geographical Segment: India
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Switzerland
Performance
Geographical Segment: The Netherlands
Performance
Geographical Segment: United States
Performance
R&D Overview
Abbott Laboratories – SWOT Analysis
SWOT Analysis – Overview
Abbott Laboratories – Strengths
Abbott Laboratories – Weaknesses
Abbott Laboratories – Opportunities
Abbott Laboratories – Threats
Abbott Laboratories – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Abbott Laboratories, Medical Equipment, Deals By Year, 2014 to YTD 2020
Abbott Laboratories, Medical Equipment, Deals By Type, 2014 to YTD 2020
Abbott Laboratories, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 21, 2020: Quest Diagnostics begins to perform COVID-19 Antibody Testing
Apr 16, 2020: C-Hear Executive Dylan Rafaty reappointed as Vice-Chair to Committee On People with Disabilities by Texas Governor Greg Abbott
Apr 16, 2020: Abbott reports first-quarter 2020 results
Feb 11, 2020: Abbott Laboratories: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officer
Jan 22, 2020: Abbott reports fourth-quarter 2019 results; announces strong forecast for 2020
Jan 08, 2020: ABBOTT LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
Nov 13, 2019: Abbott announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020
Nov 06, 2019: Abbott announces discovery of new strain of HIV, keeping global health community a step ahead of the virus
Oct 29, 2019: Abbott to build medical device manufacturing facility in Indiana
Oct 16, 2019: Abbott reports third-quarter 2019 results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Abbott Laboratories, Key Facts
Abbott Laboratories, Key Employees
Abbott Laboratories, Key Employee Biographies
Abbott Laboratories, Major Products and Services
Abbott Laboratories, History
Abbott Laboratories, Other Locations
Abbott Laboratories, Subsidiaries
Abbott Laboratories, Business Unit
Abbott Laboratories, Key Competitors
Abbott Laboratories, Ratios based on current share price
Abbott Laboratories, Annual Ratios
Abbott Laboratories, Annual Ratios (Cont...1)
Abbott Laboratories, Annual Ratios (Cont...2)
Abbott Laboratories, Interim Ratios
Abbott Laboratories, Medical Equipment, Deals By Year, 2014 to YTD 2020
Abbott Laboratories, Medical Equipment, Deals By Type, 2014 to YTD 2020
Abbott Laboratories, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Abbott Laboratories, Performance Chart (2015 - 2019)
Abbott Laboratories, Ratio Charts
Abbott Laboratories, Medical Equipment, Deals By Year, 2014 to YTD 2020
Abbott Laboratories, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Abbott Laboratories (ABT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Novita Healthcare Ltd (NHL):製薬・医療:M&Aディール及び事業提携情報
    Summary Novita Healthcare Ltd (Novita Healthcare), formerly Avexa Ltd is a medical technology company that focuses on the measurement and treatment of attention difficulties in early childhood. The company operates through its subsidiary The Tali technology, which is developing a tablet based softwa …
  • Torc Oil and Gas Ltd (TOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Torc Oil and Gas Ltd (TORC) is an oil and gas company that offers oil and gas exploration and development services. The company’s services include acquisition, exploration, operations, management, production and development of crude oil and natural gas assets in Western Canadian Sedimentary …
  • Cascade Metrix LLC:企業の製品パイプライン分析
    Summary Cascade Metrix LLC (CMI) is a medical technology company that offers automated POC blood analyzer for critical care. The company offers novel micro-volume IV extension kits, and automated glucose monitoring systems, among others. It also provides a revolutionary ex vivo blood analysis system …
  • Fujikoh Company Ltd-エネルギー分野:企業M&A・提携分析
    Summary Fujikoh Company Ltd (Fujikoh Company) is a clean technology company that offers waste recycling services. The company provides biomass and environmental recycling services. It offers construction waste recycling, waste food recycling and termite dismantling and demolition services. Fujikoh C …
  • Kuala Lumpur Kepong Berhad (KLK):企業の財務・戦略的SWOT分析
    Kuala Lumpur Kepong Berhad (KLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Chesapeake Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Chesapeake Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Chesapeake Energy Corp (Chesapeake) is an upstream oil and gas company in the US. The company explores for, develops and produces oil and gas from its assets. It has liquid operations in Eagle …
  • Bausch Health Companies Inc (VRX):医療機器:M&Aディール及び事業提携情報
    Summary Bausch Health Companies Inc(Bausch Health) formerly known as Valeant Pharmaceuticals International Inc, develops, manufactures and markets several branded, over-the-counter (OTC) and generic drugs. The company also offers medical devices such as medical contact lenses, intraocular lenses, op …
  • Hua Xia Bank Co., Limited :企業の戦略・SWOT・財務情報
    Hua Xia Bank Co., Limited - Strategy, SWOT and Corporate Finance Report Summary Hua Xia Bank Co., Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Northfork Electric Cooperative Inc:企業の戦略的SWOT分析
    Northfork Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • SiteOne Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SiteOne Therapeutics Inc (SiteOne) is a biopharmaceutical company that develops novel non-opioid pain therapeutics for the treatment of acute and chronic pain. The company’s lead therapeutic candidates include ST-2427 Intravenous, for post-operative pain; ST-SubQ Subcutaneous and ST-Oral, fo …
  • Botswana Power Corporation:企業の戦略的SWOT分析
    Botswana Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Halozyme Therapeutics Inc (HALO):医療機器:M&Aディール及び事業提携情報
    Summary Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid …
  • Solco Biomedical Co Ltd (043100):医療機器:M&Aディール及び事業提携情報
    Summary Solco Biomedical Co Ltd (Solco) is a medical device company that manufactures surgical instruments. The company develops and produces implants for orthopedics, neurosurgery, surgical instruments and home functional health products. Its surgical instruments comprise forceps, scissors, needle …
  • Lyka Labs Ltd (LYKALABS):企業の財務・戦略的SWOT分析
    Summary Lyka Labs Ltd (Lyka Labs) is a manufacturer of pharmaceutical formulations and active pharmaceutical ingredients. The company provides formulations such as lyophilized injections, topical formulations of cream, ointment, foams, gels and lotions. It offers formulation research and development …
  • HTG Molecular Diagnostics Inc (HTGM):企業の財務・戦略的SWOT分析
    Summary HTG Molecular Diagnostics Inc (HTG) is a provider of instruments, reagents, and services for molecular profiling applications. The company's products include HTG edge system, HTG edgeseq reveal software and HTG edgeseq immuno-oncology assay. It develops assays and reagent systems that provid …
  • Qualcomm Inc (QCOM):企業の財務・戦略的SWOT分析
    Qualcomm Inc (QCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • CymaBay Therapeutics Inc (CBAY):製薬・医療:M&Aディール及び事業提携情報
    Summary CymaBay Therapeutics Inc (CymaBay), formerly Metabolex Inc is a clinical-stage biopharmaceutical company that develops therapeutics to treat diabetes, orphan diseases and related metabolic disorders. The company’s pipeline products comprise Arhalofenate, an oral small molecule intended for t …
  • Extendicare Inc (EXE):企業の財務・戦略的SWOT分析
    Summary Extendicare Inc (Extendicare), formerly Crownx Inc is a healthcare service provider that offers long-term care services. The center’s services include short stay care, convalescent care, home health care, group purchasing, assisted living, retirement living, workplace health and wellness, sk …
  • Tokyo Broadcasting System Holdings Inc (9401):企業の財務・戦略的SWOT分析
    Tokyo Broadcasting System Holdings Inc (9401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • International Zeolite Corp
    International Zeolite Corp - Strategy, SWOT and Corporate Finance Report Summary International Zeolite Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆